In pancreatic cancer, cells based on specific cell-surface markers (i.e. CD24+CD44+ESA+ and CD133+ cells) have been reported to possess CSC characteristics [12,16,17]. This evidence concerns the gene PROM1 and pancreatic neoplasm.